)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Akums Drugs and Pharmaceuticals (AKUMS) investor relations material
Akums Drugs and Pharmaceuticals Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 25/26 earnings summary11 Aug, 2025
Executive summary
Marked one year as a listed company, focusing on long-term growth, organizational strengthening, and key board and management appointments.
Achieved 1,000 DCGI approvals, with 27 new approvals in Q1 FY26; first European dossier approval for rivaroxaban and first Swiss dossier filed.
Received €100 million advance for a European CDMO contract, boosting cash surplus to INR 1,518 crore; commercial supplies to start April 2027.
Market volume growth remained tepid, with IPM growth mainly price-driven and API prices declining.
Approved unaudited Q1 FY26 results with no qualifications from auditors.
Financial highlights
Q1 FY26 total income reached INR 1,051 crore, up 2.4% year-over-year; consolidated revenue at ₹10,240.32 million, up from ₹10,191.13 million in Q1 FY25.
Reported EBITDA at INR 156 crore, up 19% year-over-year; margin at 14.8%, up 208 bps YoY.
Adjusted PAT at INR 65 crore, up 13% year-over-year; consolidated net profit at ₹646.85 million, up from ₹612.08 million.
Cash surplus increased to INR 1,518 crore, supported by the EU contract advance.
Basic and diluted EPS for Q1 FY26 stood at ₹2.93 (standalone) and ₹4.15 (consolidated).
Outlook and guidance
CDMO business expected to deliver mid single-digit growth for FY26, revised due to continued API price softness.
Commercialization of the EU contract is on track, with supplies starting April 2027 and annual contribution of at least INR 300 crore.
Five-year export revenue target set at $100 million, up from $15 million.
No deviation in the use of IPO funds; all proceeds utilized as planned.
Focus remains on strengthening CDMO leadership, scaling high-value capabilities, and operational excellence.
CDMO margin drivers beyond API pricing
European market entry strategy and competitive edge
Inorganic acquisition criteria and focus areas
Europe CDMO: Strategy beyond large contract?
API & Trade Generics: Path to profitability?
Inorganic growth: Target capabilities/markets?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Akums Drugs and Pharmaceuticals earnings date
Q2 25/2610 Nov, 2025
Next Akums Drugs and Pharmaceuticals earnings date
Q2 25/2610 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage